192 related articles for article (PubMed ID: 20470422)
1. Comparative proteomic analysis of plasma membrane proteins between human osteosarcoma and normal osteoblastic cell lines.
Zhang Z; Zhang L; Hua Y; Jia X; Li J; Hu S; Peng X; Yang P; Sun M; Ma F; Cai Z
BMC Cancer; 2010 May; 10():206. PubMed ID: 20470422
[TBL] [Abstract][Full Text] [Related]
2. Plasma membrane proteomic analysis of human osteosarcoma and osteoblastic cells: revealing NDRG1 as a marker for osteosarcoma.
Hua Y; Jia X; Sun M; Zheng L; Yin L; Zhang L; Cai Z
Tumour Biol; 2011 Oct; 32(5):1013-21. PubMed ID: 21706236
[TBL] [Abstract][Full Text] [Related]
3. Surface proteomic analysis of osteosarcoma identifies EPHA2 as receptor for targeted drug delivery.
Posthumadeboer J; Piersma SR; Pham TV; van Egmond PW; Knol JC; Cleton-Jansen AM; van Geer MA; van Beusechem VW; Kaspers GJ; van Royen BJ; Jiménez CR; Helder MN
Br J Cancer; 2013 Oct; 109(8):2142-54. PubMed ID: 24064975
[TBL] [Abstract][Full Text] [Related]
4. MiR-9 is overexpressed in spontaneous canine osteosarcoma and promotes a metastatic phenotype including invasion and migration in osteoblasts and osteosarcoma cell lines.
Fenger JM; Roberts RD; Iwenofu OH; Bear MD; Zhang X; Couto JI; Modiano JF; Kisseberth WC; London CA
BMC Cancer; 2016 Oct; 16(1):784. PubMed ID: 27724924
[TBL] [Abstract][Full Text] [Related]
5. Comparative proteomic analysis of human osteosarcoma and SV40-immortalized normal osteoblastic cell lines.
Guo QC; Shen JN; Jin S; Wang J; Huang G; Zhang LJ; Huang G; Yin JQ; Zou CY; Li MT
Acta Pharmacol Sin; 2007 Jun; 28(6):850-8. PubMed ID: 17506944
[TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of the surface exposed proteome of two canine osteosarcoma cell lines and normal canine osteoblasts.
Milovancev M; Hilgart-Martiszus I; McNamara MJ; Goodall CP; Seguin B; Bracha S; Wickramasekara SI
BMC Vet Res; 2013 Jun; 9():116. PubMed ID: 23758893
[TBL] [Abstract][Full Text] [Related]
7. Microarray Expression Profile and Functional Analysis of Circular RNAs in Osteosarcoma.
Liu W; Zhang J; Zou C; Xie X; Wang Y; Wang B; Zhao Z; Tu J; Wang X; Li H; Shen J; Yin J
Cell Physiol Biochem; 2017; 43(3):969-985. PubMed ID: 28957794
[TBL] [Abstract][Full Text] [Related]
8. Proteomics of osteosarcoma.
Bernardini G; Laschi M; Geminiani M; Santucci A
Expert Rev Proteomics; 2014 Jun; 11(3):331-43. PubMed ID: 24654989
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional Profiling Identifies the Signaling Axes of IGF and Transforming Growth Factor-b as Involved in the Pathogenesis of Osteosarcoma.
Yang R; Piperdi S; Zhang Y; Zhu Z; Neophytou N; Hoang BH; Mason G; Geller D; Dorfman H; Meyers PA; Healey JH; Phinney DG; Gorlick R
Clin Orthop Relat Res; 2016 Jan; 474(1):178-89. PubMed ID: 26463566
[TBL] [Abstract][Full Text] [Related]
10. Clinical importance of S100A9 in osteosarcoma development and as a diagnostic marker and therapeutic target.
Liu Y; Luo G; He D
Bioengineered; 2019 Dec; 10(1):133-141. PubMed ID: 31055998
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of KH-type splicing regulatory protein regulates proliferation, migration, and implantation ability of osteosarcoma.
Pruksakorn D; Teeyakasem P; Klangjorhor J; Chaiyawat P; Settakorn J; Diskul-Na-Ayudthaya P; Chokchaichamnankit D; Pothacharoen P; Srisomsap C
Int J Oncol; 2016 Sep; 49(3):903-12. PubMed ID: 27573585
[TBL] [Abstract][Full Text] [Related]
12. Identification of potential crucial genes and key pathways in osteosarcoma.
Liu J; Wu S; Xie X; Wang Z; Lei Q
Hereditas; 2020 Jul; 157(1):29. PubMed ID: 32665038
[TBL] [Abstract][Full Text] [Related]
13. MiR-384 Inhibits Malignant Biological Behavior Such as Proliferation and Invasion of Osteosarcoma by Regulating IGFBP3.
Tan Y; Chen L; Li S; Hao H; Zhang D
Technol Cancer Res Treat; 2020; 19():1533033820909125. PubMed ID: 32129151
[TBL] [Abstract][Full Text] [Related]
14. Identification of CD20, ECM, and ITGA as Biomarkers for Osteosarcoma by Integrating Transcriptome Analysis.
Wang DW; Yu SY; Cao Y; Yang L; Liu W; Er XQ; Yao GJ; Bi ZG
Med Sci Monit; 2016 Jun; 22():2075-85. PubMed ID: 27314445
[TBL] [Abstract][Full Text] [Related]
15. Comparative proteome analysis of saccular intracranial aneurysms with iTRAQ quantitative proteomics.
Wang J; Yu L; Huang X; Wang Y; Zhao J
J Proteomics; 2016 Jan; 130():120-8. PubMed ID: 26385002
[TBL] [Abstract][Full Text] [Related]
16. Comparative proteomic investigation of metastatic and non-metastatic osteosarcoma cells of human and canine origin.
Roy J; Wycislo KL; Pondenis H; Fan TM; Das A
PLoS One; 2017; 12(9):e0183930. PubMed ID: 28910304
[TBL] [Abstract][Full Text] [Related]
17. Quantitative proteomic analysis of human plasma using tandem mass tags to identify novel biomarkers for herpes zoster.
Wang T; Shen H; Deng H; Pan H; He Q; Ni H; Tao J; Liu S; Xu L; Yao M
J Proteomics; 2020 Aug; 225():103879. PubMed ID: 32585426
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive metabolomic profiling of osteosarcoma based on UHPLC-HRMS.
Lv D; Zou Y; Zeng Z; Yao H; Ding S; Bian Y; Wen L; Xie X
Metabolomics; 2020 Nov; 16(12):120. PubMed ID: 33210231
[TBL] [Abstract][Full Text] [Related]
19. Identification of the up-regulation of TP-alpha, collagen alpha-1(VI) chain, and S100A9 in esophageal squamous cell carcinoma by a proteomic method.
Fan NJ; Gao CF; Wang CS; Zhao G; Lv JJ; Wang XL; Chu GH; Yin J; Li DH; Chen X; Yuan XT; Meng NL
J Proteomics; 2012 Jul; 75(13):3977-86. PubMed ID: 22583932
[TBL] [Abstract][Full Text] [Related]
20. Proteomic analysis of chemonaive pediatric osteosarcomas and corresponding normal bone reveals multiple altered molecular targets.
Folio C; Mora MI; Zalacain M; Corrales FJ; Segura V; Sierrasesúmaga L; Toledo G; San-Julián M; Patiño-García A
J Proteome Res; 2009 Aug; 8(8):3882-8. PubMed ID: 19492781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
